To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented new translational data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The study demonstrates that ...

CHICAGO -- Intracerebroventricular (ICV) delivery of bivalent CAR T-cells targeting EGFR and IL13Rα2 was feasible and ...

A new technique enables rapid and accurate cell density measurement at single-cell resolution, providing insights into cell ...

Recent research points to the potential utility of a familiar sounding foe–herpes virus–in the fight against cancer.

A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...

Non-dilutive NIH funding supports development of MiNK’s allogeneic iNKT platform for immune regulation in high-risk HSCT ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid ...